Frederick C. Beddingfield III, MD, PhD

Kythera Biopharmaceuticals, Inc.
27200 West Agoura Road
Calabasas, CA
USA 91301

Papers:
ATX-101, a Submental Contouring Injectable Drug for the Reduction of Submental Fat: A Pooled Analysis of Two Pivotal Phase 3 (REFINE-1 And REFINE-2) Multicenter, Double-Blind, Randomized, Placebo-Controlled Trials